You just read:

The Osaka Study Evaluated a Typical European Transplant Population and Showed Similar Efficacy for ADVAGRAF™ and PROGRAF™ in Renal Transplantation at the Same 0.2MG/KG Starting Dose

News provided by

Astellas Pharma Europe Limited

05 Sep, 2011, 13:29 BST